News
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
StockStory.org on MSN18h
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...
our findings show how RNA may directly contribute to the stability and evolution of the genome. It's not merely a passive messenger, but an active participant in genome maintenance. These insights ...
Because they rely on hosts for a majority of functions, viruses aren’t considered alive. But entities like this one ...
2d
Barchart on MSNWhat to Expect From Moderna's Next Quarterly Earnings ReportModerna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...
Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
In the vast and often unseen world of microscopic life, a recent discovery may force scientists to rethink what it means to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results